Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-10-29Improving the Assessment and Treatment of Chronic Pain in Veterans With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2026-10-14A Multicenter, Randomized, Double-blind, Parallel Controlled Study on the Efficacy and Safety of QLM1016 in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-10-05A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-10-05Young Adults With Violent Behavior During Early Psychosis: An Open Pilot Trial
-
CLINICAL_TRIALS study record update · 2026-10-05A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study results posted · 2026-09-29A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-08-21A 52-week, Phase 2, Open-label Trial to Evaluate the Long-term Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-08-21Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-07-31The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study results posted · 2026-07-17Personalized and Scalable Cognitive Remediation Approaches
-
CLINICAL_TRIALS study results posted · 2026-06-30A Phase 1, Single Dose, Parallel Cohort Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TV-44749, Olanzapine for Extended-Release Injectable Suspension for Subcutaneous Use, in Chinese Patients With Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-06-25Network Mediation of Experiential and Expressive Deficits in Psychotic Disorders
-
CLINICAL_TRIALS study results posted · 2026-06-22A Phase 3b, Open-label, Multicenter, Two-Period, Slow-titration and Food Effect Study to Assess the Safety and Efficacy of KarXT in Participants With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-06-22A Phase II Study to Test PK Tolerability in Children and Adolescents
-
CLINICAL_TRIALS study results posted · 2026-06-18A Randomized, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Subjects With Schizophrenia
-
CLINICAL_TRIALS study results posted · 2026-06-17Multi-modal Assessment of GABA Function in Psychosis
-
CLINICAL_TRIALS study record update · 2026-06-17The Effect of Metformin Treatment on Cognitive Impairment in Individuals With Schizophrenia: A 24-week Multicentre Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-06-05A Single-Arm, Open Label, 16-week Extension Study to Evaluate the Efficacy and Safety of a Second Course of a Digital Therapeutic as an Adjunct to Standard of Care Antipsychotic Therapy in Adult and Late Adolescent Participants With Experiential Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2026-04-27Pilot Study of the Cognitive and Neurobiological Effects of the Clubhouse Model of Psychosocial Rehabilitation for Schizophrenia and Related Conditions
-
CLINICAL_TRIALS study record update · 2026-04-27Characterization of CB1 Receptors Using [11-C]OMAR
-
CLINICAL_TRIALS study record update · 2026-04-24Studies of Frontal Lobe Function During Cognitive Stimulation as Measured With Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients With Neuropsychiatric Disorders
-
CLINICAL_TRIALS study record update · 2026-04-24A Neurobiological Investigation of Patients With Schizophrenia Spectrum Disorders and Their Siblings
-
CLINICAL_TRIALS study record update · 2026-04-24Inpatient Evaluation of Neuropsychiatric Patients
-
CLINICAL_TRIALS study record update · 2026-04-24A Phase 1b, Randomized, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of SEP-380135 in Adults With Schizophrenia or With a Major Depressive Episode Associated With Bipolar I or II Disorder or Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2026-04-24Clinical Trials for Neuroimaging and Electrophysiology in Schizophrenic Patients With Negative Symptoms Using Transcranial Direct Current Stimulation